BioMarin?s dwarfism treatment improves growth in mid-stage study
 

BioMarin?s dwarfism treatment improves growth in mid-stage study
June 17 (Reuters) - BioMarin Pharmaceutical Inc said its experimental drug was effective in improving growth in children with the most common form of dwarfism in a mid-stage study. http://feeds.feedburner.com/~ff/reut...?d=yIl2AUoC8zA http://feeds.feedburner.com/~ff/reut...Ig:F7zBnMyn0Lo http://feeds.feedburner.com/~ff/reut...Ig:V_sGLiPBpWU
http://feeds.feedburner.com/~r/reute...~4/xZMV-SmsFTA